UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline

Canadian family physician, 2018-05, Vol.64 (5), p.339-351

2018

Volltextzugriff (PDF)

“Kind of blurry”: Deciphering clues to prevent, investigate and manage prescribing cascades

PloS one, 2022-08, Vol.17 (8), p.e0272418-e0272418

2022

Volltextzugriff (PDF)

What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process

PloS one, 2015-04, Vol.10 (4), p.e0122246-e0122246

2015

Volltextzugriff (PDF)

Patient and provider perspectives on the development and resolution of prescribing cascades: a qualitative study

BMC geriatrics, 2020-09, Vol.20 (1), p.368-11, Article 368

2020

Volltextzugriff (PDF)

Survey content validation evaluating the dissemination and implementation of deprescribing guidelines

Basic & clinical pharmacology & toxicology, 2024-01, Vol.134 (1), p.63-71

2024

Volltextzugriff (PDF)

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing

PloS one, 2016-08, Vol.11 (8), p.e0161248

2016

Volltextzugriff (PDF)

What do clinical practice guidelines say about deprescribing? A scoping review

BMJ quality & safety, 2024-05, p.bmjqs-2024-017101

2024

Volltextzugriff (PDF)

Engaging patients in conversations about deprescribing

Expert review of clinical pharmacology, 2024-06, Vol.17 (5-6), p.419-422

Farrell, Barbara

2024

Volltextzugriff (PDF)

Managing clinical trials

Trials, 2010-07, Vol.11 (1), p.78-78, Article 78

2010

Volltextzugriff (PDF)

Trial (management) and error

The Lancet (British edition), 2019-05, Vol.393 (10184), p.1935-1936

Farrell, Barbara

2019

Volltextzugriff (PDF)

Deprescribing Is an Essential Part of Good Prescribing

American family physician, 2019-01, Vol.99 (1), p.7-9

2019

Volltextzugriff (PDF)

Supporting deprescribing in long-term care: An approach using stakeholder engagement, behavioural science and implementation planning

Exploratory research in clinical and social pharmacy, 2022-09, Vol.7, p.100168-100168, Article 100168

2022

Volltextzugriff (PDF)

Earnings Management of Firms Reporting Material Internal Control Weaknesses under Section 404 of the Sarbanes-Oxley Act

Auditing : a journal of practice and theory, 2008-11, Vol.27 (2), p.161-179

2008

Volltextzugriff (PDF)

Applying the Behaviour Change Wheel to support deprescribing in long-term care: Qualitative interviews with stakeholder participants

Exploratory research in clinical and social pharmacy, 2023-03, Vol.9, p.100256-100256, Article 100256

2023

Volltextzugriff (PDF)

Communicating adverse drug events: serotonin toxicity

Prescriber (London, England), 2023-11, Vol.34 (11-12), p.19-24

Farrell, Barbara

2023

Volltextzugriff (PDF)

Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care

Journal of the American Medical Directors Association, 2016-07, Vol.17 (7), p.673.e1-673.e4

2016

Volltextzugriff (PDF)

Ranking of Accounting Doctoral Programs Based on Student Ratings in Ratemyprofessors.com and the Effect of Formal Teaching Training on the Rankings

International journal of doctoral studies, 2019, Vol.14, p.307-324

2019

Volltextzugriff (PDF)

Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action

European journal of internal medicine, 2017-03, Vol.38, p.3-11

2017

Volltextzugriff (PDF)

Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals

Trials, 2020-05, Vol.21 (1), p.384-384, Article 384

2020

Volltextzugriff (PDF)

Impact on confidence and practice: How the ADAPT online patient care skills program made a difference for pharmacists

Research in social and administrative pharmacy, 2019-10, Vol.15 (10), p.1251-1258

2019

Volltextzugriff (PDF)

Part I: Interactive case: Rational deprescribing of benzodiazepine receptor agonists for insomnia

JAACP : Journal of the American College of Clinical Pharmacy, 2022-03, Vol.5 (3), p.370-376

Farrell, Barbara

2022

Volltextzugriff (PDF)

Using Community Engagement to Initiate Conversations About Medication Management and Deprescribing in Primary Care

Journal of community engagement and scholarship, 2022-06, Vol.15 (1), p.4

2022

Volltextzugriff (PDF)

Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Pilot and feasibility studies, 2023-05, Vol.9 (1), p.84-19, Article 84

2023

Volltextzugriff (PDF)

Deprescribing: what is it and what does the evidence tell us?

Canadian journal of hospital pharmacy, 2013-05, Vol.66 (3), p.201-202

2013

Volltextzugriff (PDF)

1 – 25 von 474

Suche als RSS-Feed

Aktive Filter

PublikationsformBerichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(399)
Mit Volltextzugriff
(391)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline

“Kind of blurry”: Deciphering clues to prevent, investigate and manage prescribing cascades

What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process

Patient and provider perspectives on the development and resolution of prescribing cascades: a qualitative study

Survey content validation evaluating the dissemination and implementation of deprescribing guidelines

Methodology for Developing Deprescribing Guidelines: Using Evidence and GRADE to Guide Recommendations for Deprescribing

What do clinical practice guidelines say about deprescribing? A scoping review

Engaging patients in conversations about deprescribing

Managing clinical trials

Trial (management) and error

Deprescribing Is an Essential Part of Good Prescribing

Supporting deprescribing in long-term care: An approach using stakeholder engagement, behavioural science and implementation planning

Earnings Management of Firms Reporting Material Internal Control Weaknesses under Section 404 of the Sarbanes-Oxley Act

Applying the Behaviour Change Wheel to support deprescribing in long-term care: Qualitative interviews with stakeholder participants

Communicating adverse drug events: serotonin toxicity

Effect of a Proton Pump Inhibitor Deprescribing Guideline on Drug Usage and Costs in Long-Term Care

Ranking of Accounting Doctoral Programs Based on Student Ratings in Ratemyprofessors.com and the Effect of Formal Teaching Training on the Rankings

Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action

Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial

Where do we go from here? - Opportunities and barriers to the career development of trial managers: a survey of UK-based trial management professionals

Impact on confidence and practice: How the ADAPT online patient care skills program made a difference for pharmacists

Part I: Interactive case: Rational deprescribing of benzodiazepine receptor agonists for insomnia

Using Community Engagement to Initiate Conversations About Medication Management and Deprescribing in Primary Care

Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy

Deprescribing: what is it and what does the evidence tell us?

Aktive Filter

Suchergebnisse filtern